@llhuscg Speaking about HIFU & TULSA, I received this email yesterday:
“Anthem Blue Cross, the largest for-profit member of the Blue Cross Blue Shield Association (serving more than 40 million members), recently reviewed its medical policy on High Intensity Focused Ultrasound (HIFU) for localized prostate cancer. Anthem has determined that HIFU treatment is “not medically necessary,” despite support from the urologic oncology community. Both Medicare and other major commercial plans such as United Healthcare are already covering the HIFU procedure.
The non-coverage policy from Anthem represents a major step back that limits patient access to a non-invasive treatment option and undermines individualized care based on the patient-physician shared decision-making principle.
While many of your members may not have had direct experience with HIFU, this effort represents a meaningful opportunity to advocate for broader coverage and access, making this treatment option available to more men across the United States.“
So, just to be sure that I wasn’t being scammed, I checked on Anthem’s web site about this. This from Anthem’s website, effective last week: https://www.anthem.com/medpolicies/abc/active/gl_pw_d091799.html
@brianjarvis
HIFU is one of the multiple types of focal therapy. Comments like this may be one reason treatment was stopped.
At the 11/1/2025 PCRI conference the following was said by Matthew R. Cooperberg, MD, MPH
What about focal therapy?
* The energy modality matters much less than the accuracy of the imaging - which is not there yet.
* Overall focal therapy is associated with minor side effects, but high rates of recurrence both in- and out-of-field.
* Focal therapy is not really a replacement for surgery or radiation; it is better considered an adjunct to active surveillance